3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
17
Melanoma
15
Head and Neck Neoplasms
15
Carcinoma, Renal Cell
12
Carcinoma, Non-Small-Cell Lung
12
Stomach Neoplasms
8
Uterine Cervical Neoplasms
7
Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Carcinoma, Merkel Cell
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Urogenital Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Microsatellite Instability
2
Mesothelioma, Malignant
2
Mesothelioma
2
Gastrointestinal Neoplasms
2
Interventions
pembrolizumab
8
Radiotherapy
2
Nivolumab
2
Drug Therapy
2
Biopsy
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
cc-486
1
brodalumab
1
atezolizumab
1
Trastuzumab
1
Therapeutics
1
Surveys and Questionnaires
1
Semaxinib
1
SUB1 protein, human
1
Radiosurgery
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Lighting
1
Isotretinoin
1
Interleukin-2
1
Interferon-alpha
1
Injections
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
atezolizumab
×
Head & Neck
×
Clear all
NCT04273061
2025-09-22
CAPTIV-8
British Columbia Cancer Agency
Phase 2
Recruiting
200 enrolled